Dr mohammed abdelgawad crbsi

49
Catheter Related Blood Stream Infection (CRBSI) Diagnosis & Management Step-Wise Practical Approach in HD Patients Mohammed Abdel Gawad Nephrology Specialist Kidney & Urology Center (KUC) Alexandria – EGY [email protected] 1 st Annual Interventional Nephrology Meeting – ESNT Mansoura, 26-27/Oct/2017

Transcript of Dr mohammed abdelgawad crbsi

Page 1: Dr mohammed abdelgawad   crbsi

Catheter Related Blood Stream Infection (CRBSI)

Diagnosis & Management Step-Wise Practical Approach in HD Patients

Mohammed Abdel GawadNephrology Specialist

Kidney & Urology Center (KUC)

Alexandria – EGY

[email protected]

1st Annual Interventional Nephrology Meeting – ESNTMansoura, 26-27/Oct/2017

Page 2: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 3: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 4: Dr mohammed abdelgawad   crbsi

Paired Blood Cultures

Peripheral vein

From the catheter

Culture of the catheter tip (distal 5 cm)

or

Page 5: Dr mohammed abdelgawad   crbsi

Paired Blood Cultures

or

When a peripheral blood sample cannot be obtained

From the catheter

From Dialysis circuit

2 quantitative blood cultures of samples obtained through

2 catheter lumens

Page 6: Dr mohammed abdelgawad   crbsi

Culture Results

Results Diagnosis

Same organism from both samples CRBSI Confirmed

Both negative CRBSI Unlikely

Negative peripheral blood cultureBUT

Positive central blood culture

Probably contamination (don’t treat EXCEPT if

Staph. Aureus)

Page 7: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 8: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 9: Dr mohammed abdelgawad   crbsi
Page 10: Dr mohammed abdelgawad   crbsi
Page 11: Dr mohammed abdelgawad   crbsi

Pathway 1: Catheter Salvage

Start Empirical Antibiotics + Antibiotic Lock Therapy

Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)

Improving?

Yes

Continue antibotics, then:

Pathway 3: Surveillance

No

Pathway 4: Catheter removal

Pathway 1: Catheter Salvage

Page 12: Dr mohammed abdelgawad   crbsi

Empirical Antibiotics Antibiotic To cover Condition

Vancomycin MRSA for institutions in with preponderance of MRSA

Gentamycin(if absolutely

contraindicated use Quinolones)

Gram –ve---------------------

Meropenem, Imipenemor Etrapenem

or Piperacillin/Tazobactamin community with low incidence of antibiotic

resistance

MDR Gram –ve In neutropenic patients, severely ill patients with sepsis, or patients

known to be colonized with such pathogens

Fluconazole or Echinocandin

Candidemia total parenteral nutrition, prolonged use ofbroad-spectrum antibiotics, hematologic

malignancy, receipt of bone marrow or solid-organ transplant, femoral catheterization,or colonization due to Candida species at

multiple sites

Page 13: Dr mohammed abdelgawad   crbsi

Alternatives to vancomycin as a first choice broad spectrum

Condition Alternative

the preponderance of MRSA isolates have vancomycin

minimum inhibitory concentration (MIC) values 12

mg/mL

Daptomycin

Page 14: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: VANCOMYCIN

2017

Page 15: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: GENTAMICIN

2017

Page 16: Dr mohammed abdelgawad   crbsi

Dialyziability & Residual Renal Function Effect

• Vancomycin is not removed by HD; gentamicin is.

• Measure gent levels daily (levels will decrease sooner in patients with significant residual function).

• Monitor predialysis trough levels if possible

2017

Page 17: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: MEROPENEM

2017

Page 18: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: IMIPENEM

2017

Page 19: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: ERTAPENEM

2017

Page 20: Dr mohammed abdelgawad   crbsi

Antibiotic Doses: PIPERACILLIN/TAZOBACTAM

2017

Page 21: Dr mohammed abdelgawad   crbsi

Antifungal Doses: FLUCONAZOL

2017

Page 22: Dr mohammed abdelgawad   crbsi

Pathway 1: Catheter Salvage

Start Empirical Antibiotics + Antibiotic Lock Therapy

Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)

Improving?

Yes

Continue antibiotics, then:

Pathway 3: Surveillance

No

Pathway 4: Catheter removal

Pathway 1: Catheter Salvage

Page 23: Dr mohammed abdelgawad   crbsi
Page 24: Dr mohammed abdelgawad   crbsi
Page 25: Dr mohammed abdelgawad   crbsi

Pathway 1: Catheter Salvage

Start Empirical Antibiotics + Antibiotic Lock Therapy

Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)

Improving?

Yes

Continue antibiotics, then:

Pathway 3: Surveillance

No

Pathway 4: Catheter removal

Pathway 1: Catheter Salvage

Duration of Systemic and

Antibiotic Lock

Page 26: Dr mohammed abdelgawad   crbsi

Duration of Systemic and Antibiotic Lock

Pathway 1: Catheter Salvage

If catheter is retained for a patient with S. aureus CRBSI

Continue systemic and antibiotic

lock therapy for 4 weeks

Page 27: Dr mohammed abdelgawad   crbsi

Duration of Systemic and Antibiotic Lock

Pathway 1: Catheter Salvage

If catheter is retained for a patient with any other organism

No clear data for systemic and antibiotic lock therapy salvage

duration

Page 28: Dr mohammed abdelgawad   crbsi

Antibiotic Lock Special Situation

Multiple positive catheter blood culture BUT concurrent negative peripheral

blood cultures

Antibiotic lock therapy without systemic therapy for 10–14 days

Page 29: Dr mohammed abdelgawad   crbsi
Page 30: Dr mohammed abdelgawad   crbsi

guide wire

Start Empirical Antibiotics as in salvage pathway

Reassess after 2-3 days: Clinically (fever) & Lab (WBC, CRP)

Improving?

Yes

Exchange on guide wire

Continue antibiotics

Pathway 3: Surveillance

No

Pathway 4: Catheter removal

Pathway 2: Exchange on guide wire

Duration of Systemic and

Antibiotic Lock

Page 31: Dr mohammed abdelgawad   crbsi

Duration of Systemic and Antibiotic Lock

If catheter is exchanged for a patient with any organism

No clear data for systemic and antibiotic lock therapy salvage

duration

Pathway 2: Exchange on guide wire

Page 32: Dr mohammed abdelgawad   crbsi
Page 33: Dr mohammed abdelgawad   crbsi

Pathway 3: Surveillance

bloodstream infection that continuesdespite >72 h of antimicrobial therapy

to which the infecting microbes are susceptible

2 sets of blood cultures obtained on a given day

Page 34: Dr mohammed abdelgawad   crbsi

Pathway 3: Surveillance If the catheter has been retained

Surveillance blood cultures 1 week after completion of an antibiotic course

If blood cultures +ve → the catheter should be removed

New, long term dialysis catheter after additional –ve blood cultures

Page 35: Dr mohammed abdelgawad   crbsi
Page 36: Dr mohammed abdelgawad   crbsi

Pathway 4: Catheter removal

Remove catheter and culture tip (5 cm)

Start empirical antibiotics as in salvage pathway

Is access is needed urgently for dialysis?

Yes

Insert temporary catheter in

another site for short

period of time

No

Continue antibiotics

Insert long term catheter ONLY if:

1- afebrile for 48-72 hours

2- CRP is normal

3- Blood cultures are -ve

Duration?

Page 37: Dr mohammed abdelgawad   crbsi

Pathway 4: Catheter removal

Page 38: Dr mohammed abdelgawad   crbsi

Persistent fungemia or bacteremia >72 h after catheter

removal

4 to 6 weeks of antibiotic therapy

should be administered

Additional TEE should be obtained

Catheter Removal Special Situation (1)

Page 39: Dr mohammed abdelgawad   crbsi

Catheter Removal Special Situation (2)

Catheter tip grows S. aureus

but

Initial peripheral blood cultures -ve

5–7-day course of antibiotics

Close monitoring for signs and symptoms of ongoing infection, including additional blood cultures, as indicated

Page 40: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 41: Dr mohammed abdelgawad   crbsi

Talk Outline

• Diagnosis

• Management

• Prevention

Page 42: Dr mohammed abdelgawad   crbsi

Prevention - Catheter

• Strict aseptic circumstances.

• Avoid as much as possible:

– using non-tunneled catheters.

– using femoral

• Monitor the catheter:

– visually when changing the dressing

– or by palpation through an intact dressing on aregular basis.

Page 43: Dr mohammed abdelgawad   crbsi

Prevention – Exit Site

• Application of antibiotic ointment at the exitsite until the insertion site has healed

• The catheter exit site should be covered by adressing as long as the catheter remains inplace.

Page 44: Dr mohammed abdelgawad   crbsi

Prevention – Antimicrobial Lock

• Its use is debated.

• Its use may be saved to patients with:– history of multiple CRBSI – those with high risk of severe sequelae (patients

with pacemakers, prosthetic valve or IV devices).

• Citrate locks have, for the time being, most extensively been studied. (The 4% solution seems to offer at present the best benefit/risk ratio).

Page 45: Dr mohammed abdelgawad   crbsi

Prevention – Staphylococcus

• Eradication of Staphylococcus carriage (nasal mupirocin cream).

• Consider IV antibiotics at insertion for patients with Staphylococcal skin colonisation.

Page 46: Dr mohammed abdelgawad   crbsi

Always re-evaluate for alternative access

(AVF or AVG).

Page 47: Dr mohammed abdelgawad   crbsi

References

Page 48: Dr mohammed abdelgawad   crbsi

References

Page 49: Dr mohammed abdelgawad   crbsi

Thank You